Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
ARWR —
ARROWHEAD PHARMACEUTICALS IN
CUSIP: 04280A100 · Held by 2 superinvestors · Combined value: $55,437,310
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $51,456,167 | 775,059 | ADD | +266,545 |
| 2 | Ray Dalio | 0.0% | $3,981,143 | 59,966 | NEW BUY | +59,966 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ray Dalio | NEW BUY | +59,966 | New |
| Ken Griffin | ADD | +266,545 | +52.4% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +186,769 | +58.0% |
Who Owns ARWR? Superinvestor Holdings
ARROWHEAD PHARMACEUTICALS IN is held by 2 tracked superinvestors, with a combined position value of $55 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Ray Dalio (0.0% of portfolio).
In the most recent quarter, 2 superinvestors added or initiated positions.